Prevent Blindness, the nation's leading nonprofit eye health organization, is announcing Dec. 2-8, 2024, as its fourth annual Geographic Atrophy (GA) Awareness Week. GA is an advanced form of dry ...

Stem cell therapies provide hope for patients with heart disease, blindness, Parkinson's, HIV, diabetes and spinal cord ...

Few pharmaceutical products have taken the market by storm like Roche’s Vabysmo. | Interim results from a late-stage trial of ...

The California Institute for Regenerative Medicine has funded Keck School of Medicine of USC translational research advancing ...

SpaMedica has expanded its range of eye care services and increased the number of hospitals offering treatment, improving NHS ...

After many false starts, wearables now aren’t just for fun, they are streamlined tools to help those with low vision, ...

Adverum Biotechnologies advances wet AMD treatment with promising trial results. See why ADVM stock has potential as it ...

(NASDAQ: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients with serious retinal diseases ... pivotal clinical trials as a sustained ...

Ms. Connell is a commercial executive with business development expertiseAppointment takes place as Opthea prepares for Phase 3 wet AMD topline ...

New data presented at the American Society of Retina Specialists 2024 examine the benefits and adverse event profiles of two ...

A new study from researchers at Wilmer Eye Institute, Johns Hopkins Medicine explains not only why some patients with wet age-related macular degeneration (or "wet" AMD ... "This work exposes a way to ...